Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
Titel:
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
Auteur:
Ludvik, Bernhard Frías, Juan P Tinahones, Francisco J Wainstein, Julio Jiang, Honghua Robertson, Kenneth E García-Pérez, Luis-Emilio Woodward, D Bradley Milicevic, Zvonko